Kestra Advisory Services’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,045	Closed	-$127K	–	3162
2025 Q4	$127K	Buy	+10,045	New	+$115K	﹤0.01%	3245
2024 Q2	–	Sell	-30,250	Closed	-$183K	–	2616
2024 Q1	$183K	Buy	30,250 +4,999	+20%	+$28.2K	﹤0.01%	2301
2023 Q4	$153K	Buy	25,251 +1	+0%	+$4	﹤0.01%	2155
2023 Q3	$107K	Sell	25,250 -1,400	-5%	-$5.22K	﹤0.01%	2015
2023 Q2	$82.6K	Hold	26,650	–	–	﹤0.01%	2016
2023 Q1	$37K	Sell	26,650 -658	-2%	-$1.31K	﹤0.01%	2004
2022 Q4	$54.3K	Buy	27,308 +1,471	+6%	+$3.3K	﹤0.01%	2174
2022 Q3	$52K	Sell	25,837 -649	-2%	-$1.82K	﹤0.01%	2028
2022 Q2	$84K	Buy	26,486 +814	+3%	+$2.95K	﹤0.01%	2003
2022 Q1	$107K	Buy	25,672 +299	+1%	+$1.32K	﹤0.01%	1927
2021 Q4	$122K	Sell	25,373 -1,511	-6%	-$7.53K	﹤0.01%	1929
2021 Q3	$144K	Buy	+26,884	New	+$135K	﹤0.01%	2023